Please note..

The Patient Safety Measurement Unit is developing a dashboard to support the medicines safety workstream to evidence improvement and assess impact achieved. For more information don't hesitate to contact

Medication Safety Dashboard


The medication safety dashboard is a tool being developed to support the Medicines Safety Workstream to identify best practice, opportunities for improvement and supporting spread and adoption across the nation.


It utilises a set of prescribing indicators that have been developed as part of a programme of work to promote safer use of medicines, including prescribing, dispensing, administration and monitoring.


The purpose of the indicators are to support reductions in hospital admissions that may be associated with prescribing, to reduce the risk of avoidable medicines related harms and to quantify patients at potentially increased medicines related safety risk. 


  • The content is based on consideration of the medicines safety related indicators that are available in the growing number of ‘dashboards’,  related information sources and data sets available.


  • The MSD only contains a selected number of medicines safety indicators for the purpose of supporting local focus, with input from across the AHSN on choice of indicators and content.


  • This MSD approach is aimed at developing and supporting collaborative based working across the AHSN on improving medication safety on MSD indicators areas of local interest.


  • The initial content is based on consideration of the indicators available within the  ePACT2 system. There will be the option to include indicators from other information sources as this approach is developed.


  • The MSD does not state where best practice targets are for the indicators involved, in recognition of the fact that specific best practice positions may be dependent on local circumstances and therefore should be locally determined.

 Ref      Polypharmacy


P1.85    The average number of unique medicines prescribed per patient - for patients  ≥85 years old

P2.75    Percentage of patients with an anticholinergic burden score of 6 or more aged 75 and over

P3.9      Percentage of patients with an anticholinergic burden score ≥9

P4          Percentage of patients prescribed medicines likely to cause Acute Kidney Injury DAMN  (Diuretics/ACI&ARBs/Metformin/NSAIDS) drugs

P5          Percentage of patients prescribed a NSAID and ≥ 1 other unique medicines likely to cause kidney injury  (DAMN drugs)

P6 s      Percentage of patients prescribed multiple anticoagulant regimes


Ref                  Gastrointestinal Bleed Risk


S1 (GIB01)      Patients ≥65 years old prescribed a NSAID and NOT concurrently prescribed a gastro-protective medicine

S2 (GIB02)      Patients ≥18 years old prescribed a NSAID and concurrently prescribed an oral anticoagulant (warfarin or NOAC)

S3 (GIB0)        Patients ≥18 years old prescribed an oral anticoagulant (warfarin or a non-vitamin K antagonist oral anticoagulant (NOAC)) with an anti-platelet and NOT concurrently prescribed a gastroprotective medicine

S4 (GIB04)      Patients ≥18 years old prescribed aspirin and another antiplatelet and NOT concurrently prescribed a gastro-protective medicine

S5 (GIBC1)     Composite Gastro Intestinal Bleeds comprising of unique patients from indicators 1 to 4

S6 v                 Total volumes of oral     NSAIDS (ADQs per STARPU)


Ref         Respiratory 


R1           High dose ICS Inhaled Corticosteriod items as a % of all ICS items 

R2           The proportion of patients receiving 5 or fewer prescription items of ICS LABA products over 12 months

R3           Asthma patients prescribed 6 or more SABA inhalers over 12 months



Which report would you like to view?

You can navigate directly to the reports that you are looking for by selecting the option relevant to you below:-

  • Access Practice Level Data

  • CCG Level Reports
  • STP Level Reports
  • AHSN Level Reports
  • Practice Benchmarking within CCGs
  • Similar 10 CCG Benchmarking
  • Guidance and resources
The West of England Medication Safety Dashboard will be accessible via this link in the near future

Links to useful websites

The medication safety dashboard is a tool to support quality improvement. Users of the dashboard should maintain a focus on improvement. The tool should not be used for performance management. It is intended to assist users to identify opportunities for sharing best practice. It should be accompanied by a positive narrative. If you want more information on measurement for improvement, please follow this link or watch this video.



Every month, the NHS in England publishes anonymised data about the drugs prescribed by GPs. But the raw data files are large and unwieldy, with more than 700 million rows. The Open Prescribing website is making it easier for GPs, managers and everyone to explore - supporting safer, more efficient prescribing.


Please follow this link to access the website

You might find the following link also useful. It leads you to the medicines optimisation dashboard that was first launched in 2014 and since then NHS England has developed and refined the dashboard based on feedback from the people who use it.


Please follow this link to access the website


ePACT2 is an online application which gives authorised users access to prescription data.


You can access online analyses of prescribing data held by NHS Prescription Services. Data is available 6 weeks after the dispensing month

Please follow this link to access the website

Please click here to send us your feedback about the West of England medication safety dashboard..


We would like to hear from you